Amide Technologies Revenue and Competitors
Estimated Revenue & Valuation
- Amide Technologies's estimated annual revenue is currently $1.7M per year.
- Amide Technologies's estimated revenue per employee is $155,000
Employee Data
- Amide Technologies has 11 Employees.
- Amide Technologies grew their employee count by 0% last year.
Amide Technologies's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Operating Officer | Reveal Email/Phone |
3 | Sr Scientist | Reveal Email/Phone |
4 | Research Associate, Protein Sciences | Reveal Email/Phone |
5 | Senior Scientist Chemistry | Reveal Email/Phone |
6 | Jr. Mechanical Engineer | Reveal Email/Phone |
Amide Technologies Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Amide Technologies?
Amide is at the forefront of a new biotech industry—fully synthetic proteins—that boasts the combinatorial flexibility of small molecules, alongside the physiological advantages of biologics. As the experts in this new field, we champion the protein therapeutic 2.0 market. Amide was founded on the seminal inventions of Prof. Brad Pentelute enabling on-demand protein synthesis including non-natural chemical modifications - providing unique protein functionality (affinity, stability, bioavailability, cell membrane penetration) and reduced immunogenicity. Engineered synthetic proteins are coupled with our artificial intelligence (AI) tools to predict performance characteristics of our assets at a scale unattainable with traditional methods for protein synthesis and post-translational modifications. Our pipeline aims to relieve patient suffering and modify the disease course of autoimmune diseases, inflammatory disorders, cancers and COVID19.
keywords:N/A
N/A
Total Funding
11
Number of Employees
$1.7M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1M | 11 | N/A | N/A |
#2 | $1.8M | 11 | N/A | N/A |
#3 | $3.5M | 11 | -31% | $116.2M |
#4 | $2.9M | 11 | 0% | N/A |
#5 | $0.9M | 11 | -45% | $107M |